{"nct_id":"NCT03283826","title":"Phase 1/2 Study to Evaluate the Safety and Efficacy of ATA188 in Subjects With Progressive Multiple Sclerosis","status":"TERMINATED","status_verified_date":"2024-02","start_date":"2017-10-19","start_date_type":"ACTUAL","primary_completion_date":"2023-11-09","primary_completion_date_type":"ACTUAL","completion_date":"2024-01-17","completion_date_type":"ACTUAL","phases":["PHASE1","PHASE2"],"tickers":["ATRA"]}